Innate Pharma Announces Its Participation in Upcoming Investor Conference

Regulatory News:


Innate Pharma SA today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below.


Van Lanschot Kempen...

Related Keywords

France ,Amsterdam ,Noord Holland ,Netherlands ,French ,Van Lanschot Kempen ,French Financial Markets Authority ,Astrazeneca ,Exchange Commission ,Company Annual Report On Form ,Linkedin ,Euronext ,Nasdaq ,Regulatory News ,Euronext Paris ,Lanschot Kempen ,Engager Therapeutics ,Innate Pharma ,Private Securities Litigation Reform Act ,Risk Factors ,Universal Registration Document ,Annual Report ,Markets ,